What is the appropriate approach to manage a 50-year-old male with immune-mediated thrombocytopenia on prednisolone who presents with 7 days of loose stools, urge to defecate, 5 days of generalized weakness, stable vital signs, and a platelet count of 122 ×10³/µL?

Approach to This Case

This patient requires immediate evaluation for infectious diarrhea and assessment of corticosteroid-related complications, while his ITP management needs optimization given the subtherapeutic prednisolone dose.

Immediate Clinical Assessment

1. Evaluate the Acute Gastrointestinal Illness

The 7-day history of loose stools with urgency in an immunosuppressed patient demands infectious workup:

• Stool studies: Culture, ova and parasites, Clostridioides difficile toxin, and consider viral PCR panel
• Blood cultures if fever develops (current temp 37.5°C is borderline)
• Assess hydration status: BP 100/60 mmHg suggests possible volume depletion
• Check electrolytes, renal function, and liver enzymes to evaluate for dehydration and corticosteroid complications

The generalized weakness for 5 days likely reflects dehydration, electrolyte disturbances, or infection-related fatigue rather than ITP itself, given the platelet count of 122 × 10³/µL is above critical levels.

2. Address the Inadequate ITP Management

The current prednisolone dose of 5 mg daily is grossly insufficient for ITP treatment. 1 Standard first-line therapy requires prednisone 0.5-2 mg/kg/day until platelet count increases to 30-50 × 10⁹/L 1. For a 50-year-old male (assuming ~70 kg), this translates to 35-140 mg daily, not 5 mg.

However, do NOT increase corticosteroids during active infection. The current diarrheal illness takes priority, as escalating immunosuppression could worsen an infectious process.

Bleeding Risk Assessment

With platelets at 122 × 10³/µL, this patient has minimal bleeding risk. 1 Treatment is rarely indicated with platelet counts above 50 × 10⁹/L in the absence of active bleeding, trauma, surgery, or mandated anticoagulation 1. The patient has no reported bleeding symptoms, making aggressive ITP treatment unnecessary at this moment.

Management Algorithm

Step 1: Stabilize the Acute Illness (Days 1-3)

• Fluid resuscitation: IV normal saline if dehydration confirmed
• Empiric antibiotics: Consider if bacterial enteritis suspected based on clinical presentation (high fever, bloody stools, severe systemic symptoms)
• Continue prednisolone 5 mg daily temporarily to avoid adrenal insufficiency
• Monitor vitals closely: Watch for sepsis (tachycardia, hypotension, fever)
• Daily CBC: Track platelet trends during acute illness

Step 2: Investigate Corticosteroid Complications

The patient has been on chronic low-dose corticosteroids, which carries specific risks:

• Screen for steroid-induced diabetes: Fasting glucose or HbA1c
• Check for opportunistic infections: Consider CMV, fungal pathogens if diarrhea persists
• Assess bone health: DEXA scan if prolonged steroid use anticipated
• Monitor blood pressure: Already borderline low at 100/60 mmHg

The MCV of 101 fL suggests possible macrocytosis—check B12, folate, and thyroid function to exclude other autoimmune conditions.

Step 3: Optimize ITP Management After Infection Resolves

Once the infectious workup is negative or treated, reassess ITP therapy:

If platelets remain >50 × 10⁹/L without bleeding:

• Taper prednisolone gradually to the lowest effective dose or discontinue 1
• Observation only is appropriate at this platelet level 1

If platelets drop <30 × 10⁹/L or bleeding develops:

• Increase prednisolone to 0.5-2 mg/kg/day (35-140 mg for 70 kg patient) 1
• Alternative: Dexamethasone 40 mg daily for 4 days may provide higher sustained response rates (50-80%) 1
• Taper rapidly after response to minimize corticosteroid complications 1

If inadequate response to corticosteroids:

• Consider second-line agents: rituximab, thrombopoietin receptor agonists (eltrombopag, romiplostim), or fostamatinib 1

Critical Pitfalls to Avoid

1. Do not escalate immunosuppression during active infection: This could precipitate sepsis or opportunistic infections 1

2. Do not ignore the subtherapeutic ITP dosing: While 5 mg prednisolone prevents adrenal insufficiency, it provides no therapeutic benefit for ITP 1, 2

3. Do not treat platelets >50 × 10⁹/L aggressively: Overtreatment exposes patients to unnecessary corticosteroid toxicity without mortality benefit 1

4. Do not miss C. difficile colitis: Corticosteroid use is a major risk factor, and this diagnosis would require specific antibiotic therapy

5. Do not abruptly stop corticosteroids: Even at 5 mg daily, chronic use suppresses the HPA axis—taper gradually 2

Monitoring Plan

• Daily: Vital signs, stool frequency, platelet count during acute illness
• Every 2-3 days: Electrolytes, renal function until diarrhea resolves
• Weekly: CBC with differential after ITP therapy adjustment
• Monthly: Glucose, blood pressure monitoring on chronic corticosteroids

The key is treating the acute infection first, then addressing the chronically undertreated ITP once the patient is stable.